Antibiotic Dosing in Multiple Organ Dysfunction Syndrome

被引:79
作者
Ulldemolins, Marta [1 ,2 ,3 ]
Roberts, Jason A. [2 ,4 ,5 ]
Lipman, Jeffrey [2 ,4 ]
Rello, Jordi [1 ,3 ]
机构
[1] Univ Autonoma Barcelona, Crit Care Dept, Vall Hebron Univ Hosp, VHIR, Barcelona 08035, Spain
[2] Univ Queensland, Burns Trauma & Crit Care Res Ctr, Brisbane, Qld, Australia
[3] CIBERES, Barcelona, Spain
[4] Royal Brisbane & Womens Hosp, Dept Intens Care Med, Brisbane, Qld, Australia
[5] Royal Brisbane & Womens Hosp, Dept Pharm, Brisbane, Qld, Australia
基金
英国医学研究理事会;
关键词
CRITICALLY-ILL PATIENTS; INTENSIVE-CARE-UNIT; SEVERE SEPSIS; CLINICAL PHARMACOKINETICS; ANTIMICROBIAL THERAPY; GLOMERULAR-FILTRATION; ANTIBACTERIAL AGENTS; CREATININE CLEARANCE; HYPOALBUMINEMIA; PREDICTION;
D O I
10.1378/chest.10-2371
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Although early and appropriate antibiotic therapy remains the cornerstone of success for the treatment of septic shock, few data exist to guide antibiotic dose optimization in critically ill patients, particularly those with multiple organ dysfunction syndrome (MODS). It is well known that MODS significantly alters the patient's physiology, but the effects of these variations on pharmacokinetics have not been reviewed concisely. Therefore, the aims of this article are to summarize the disease-driven variations in pharmacokinetics and pharmacodynamics and to provide antibiotic dosing recommendations for critically ill patients with MODS. The main findings of this review are that the two parameters that vary with greatest significance in critically ill patients with MODS are drug volume of distribution and clearance. Disease- and clinician-driven changes lead to an increased volume of distribution and lower-than-expected plasma drug concentrations during the first day of therapy at least. Decreased antibiotic clearance is common and can lead to drug toxicity. In summary, "front-loaded" doses of antibiotic during the first 24 11 of therapy should account for the likely increases in the antibiotic volume of distribution. Thereafter, maintenance dosing must be guided by drug clearance and adjusted to the degree of organ dysfunction. CHEST 2011; 139(5):1210-1220
引用
收藏
页码:1210 / 1220
页数:11
相关论文
共 62 条
  • [1] INTRAVENOUS CIPROFLOXACIN DISPOSITION IN OBESITY
    ALLARD, S
    KINZIG, M
    BOIVIN, G
    SORGEL, F
    LEBEL, M
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 54 (04) : 368 - 373
  • [2] [Anonymous], 2010, Clinical Pharmacokinetics and Pharmacodynamics: Concepts and Applications
  • [3] Pharmacokinetics and pharmacodynamics of sequential intravenous and subcutaneous teicoplanin in critically ill patients without vasopressors
    Barbot, A
    Venisse, N
    Rayeh, F
    Bouquet, S
    Debaene, B
    Mimoz, O
    [J]. INTENSIVE CARE MEDICINE, 2003, 29 (09) : 1528 - 1534
  • [4] PHARMACOKINETICS OF ERYTHROMYCIN IN PATIENTS WITH SEVERE CIRRHOSIS - RESPECTIVE INFLUENCE OF DECREASED SERUM BINDING AND IMPAIRED LIVER METABOLIC CAPACITY
    BARRE, J
    MALLAT, A
    ROSENBAUM, J
    DEFORGES, L
    HOUIN, G
    DHUMEAUX, D
    TILLEMENT, JP
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 23 (06) : 753 - 757
  • [5] INFLUENCE OF WEIGHT ON AMINOGLYCOSIDE PHARMACOKINETICS IN NORMAL WEIGHT AND MORBIDLY OBESE PATIENTS
    BAUER, LA
    EDWARDS, WAD
    DELLINGER, EP
    SIMONOWITZ, DA
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 24 (05) : 643 - 647
  • [6] VANCOMYCIN PHARMACOKINETICS IN NORMAL AND MORBIDLY OBESE SUBJECTS
    BLOUIN, RA
    BAUER, LA
    MILLER, DD
    RECORD, KE
    GRIFFEN, WO
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 21 (04) : 575 - 580
  • [7] AMERICAN-COLLEGE OF CHEST PHYSICIANS SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE - DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    ABRAMS, JH
    BERNARD, GR
    BIONDI, JW
    CALVIN, JE
    DEMLING, R
    FAHEY, PJ
    FISHER, CJ
    FRANKLIN, C
    GORELICK, KJ
    KELLEY, MA
    MAKI, DG
    MARSHALL, JC
    MERRILL, WW
    PRIBBLE, JP
    RACKOW, EC
    RODELL, TC
    SHEAGREN, JN
    SILVER, M
    SPRUNG, CL
    STRAUBE, RC
    TOBIN, MJ
    TRENHOLME, GM
    WAGNER, DP
    WEBB, CD
    WHERRY, JC
    WIEDEMANN, HP
    WORTEL, CH
    [J]. CRITICAL CARE MEDICINE, 1992, 20 (06) : 864 - 874
  • [8] BURKHARDT K, 2007, CHEMOTHERAPY, V59, P277
  • [9] Sepsis-induced cholestasis
    Chand, Nisha
    Sanyal, Arun J.
    [J]. HEPATOLOGY, 2007, 45 (01) : 230 - 241
  • [10] Principles of antibacterial dosing in continuous renal replacement therapy
    Choi, Gordon
    Gomersall, Charles D.
    Tian, Qi
    Joynt, Gavin M.
    Freebairn, Ross
    Lipman, Jeffrey
    [J]. CRITICAL CARE MEDICINE, 2009, 37 (07) : 2268 - 2282